Article written by Newcastle MEP Jude Kirton-Darling after she met with EASL Scientific Committee member Dr Helen Louise Reeves, other NE hepatologists and EASL EU Director of Public Affairs, Fiona Godfrey in Newcastle, UK, recently.
To celebrate the 50th anniversary of EASL, the Young Investigator Concerted Action Group (YI-CAG) is proud to introduce a new yearly award specifically dedicated for young fellows.
Now 4091 members from 106 countries
Issue 7 (April 2012) Management of Hepatocellular Carcinoma

These guidelines result from a joint collaboration between the European Association for the Study of the Liver (EASL) and the European Organization for Research and Treatment of Cancer (EORTC).

The EASL–EORTC Clinical Practice Guidelines provide common guidelines for the management of hepatocellular carcinoma (HCC) and define the use of surveillance, diagnosis, and therapeutic strategies recommended for patients with this type of cancer.

NEW! The EASL–EORTC Clinical Practice Guidelines on management of hepatocellular carcinoma (HCC) are now available in Spanish, Portuguese, Russian and Chinese.